Join NATF in the fight against blood clots. Donate today. Make a donation

Event Description

This special half-day educational conference will focus on treatment breakthroughs and updates on venous thromboembolism, stroke prevention in diabetes, atrial fibrillation, and more. It is designed for physicians, pharmacists, nurses, nurse practitioners, physician assistants, allied health care professionals. Patients, family members and caregivers are also encouraged to attend.

$49.99 Registration fee includes continental breakfast, networking coffee break, all clinical sessions, the Arthur A. Sasahara, MD Annual Lecture, program book, parking at the venue, and an electronic syllabus.

2.5 CME credits are available through a partnership with ScientiaCME.

 

Event Location

Joseph B. Martin Center, Harvard Medical School

The Joseph B. Martin Conference Center at Harvard Medical School, with its contemporary
glass design, is a beautiful meeting space where many important medical courses are held. It is
located within the Longwood Medical and Academic Area, among some of Boston’s most
prestigious hospitals – Brigham and Women’s Hospital, Boston Children’s Hospital, Beth Israel
Deaconess Medical Center, and Dana Farber Cancer Institute. While most strongly associated
with Harvard Medical School, there are other schools nearby, including the Massachusetts
College of Pharmacy, and various museums.

Agenda

7:30 a.m. 

Breakfast and Registration

8:30 a.m. 

Welcome and Introductions
Samuel Z. Goldhaber, MD
Gregory Piazza, MD, MS

8:35 a.m. 

Prevention of Cardiovascular Events in Diabetes
Enrico Cagliero, MD

8:50 a.m. 

Discussion/Q&A

9:00 a.m. 

Venous Thromboembolism as a Chronic Illness:  Implications for Extended Duration Anticoagulation
Samuel Z. Goldhaber, MD

9:15 

Discussion/Q&A

9:25 a.m. 

Stroke Prevention in Atrial Fibrillation: Morbidity and Mortality
Christian T. Ruff, MD, MPH

9:40 a.m. 

Discussion/Q&A

9:50 a.m. 

Coffee Break

10:20 a.m. 

Lymphedema: Our Mission to Better Understand, Diagnose, and Treat This Often Ignored Disease
Gregory Piazza, MD, MS

10:35 a.m. 

Discussion/Q&A

10:45 a.m. 

Arthur A. Sasahara, MD Annual Lecture on Thrombosis
“Implications of the COMPASS Trial: Prevention of MI and Stroke in Patients with Established CAD and PAD”
Deepak Bhatt, MD, MPH

11:10 a.m. 

Discussion/Q&A

11:20 

Closing Remarks

11:30 

Adjurn

Speakers

Deepak L. Bhatt, MD, MPH
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Professor of Medicine, Harvard Medical School

Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2016. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. Dr. Bhatt’s research interests include acute coronary syndromes, preventive cardiology, and advanced techniques in cardiac, cerebral, and peripheral intervention. He has authored or co-authored over 900 publications and serves as the editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease. Dr. Bhatt received his medical doctorate from Cornell University and a master’s degree in public health at Harvard University.

Enrico Cagliero, MD
Associate Physician, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School

Dr. Cagliero is a member of the Diabetes Unit at Massachusetts General Hospital, where he is the Director of the Inpatient Diabetes Management Program and Director for Quality for the Division of Endocrinology. He is involved in several projects focused on improving care for diabetic patients with ongoing clinical trials in type 1 diabetes and type 2 diabetes. He is the author of more than 130 research articles and several book chapters in diabetes.

Samuel Z. Goldhaber, MD
Section Head of Vascular Medicine, Brigham and Women’s Hospital Professor of Medicine, Harvard Medical School

Dr. Goldhaber is section head of Vascular Medicine and Director of the Thrombosis Research Group at Brigham and Women’s Hospital.  He serves as Principal Investigator for a broad range of randomized clinical trials and observational studies related to the prevention, treatment, and epidemiology of pulmonary embolism, deep vein thrombosis, stroke prevention in atrial fibrillation, and prevention of recurrent myocardial infarction. Dr. Goldhaber is President and a Founding Director of the North American Thrombosis Forum. For his work on prevention of venous thromboembolism, Dr. Goldhaber has received the Certificate of Appreciation from the Surgeon General of the United States.

Gregory Piazza, MD
Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital Assistant Professor of Medicine, Harvard Medical School

Dr. Piazza is an Assistant Professor of Medicine, Harvard Medical School and faculty in the Cardiovascular Division at Brigham and Women’s Hospital. In addition to his training in cardiology, he completed a National Heart Lung and Blood Institute-sponsored fellowship in vascular medicine.  Dr. Piazza’s research interests include the epidemiology, treatment, and prevention of venous thromboembolism as well as stroke prevention in atrial fibrillation.

Christian T. Ruff, MD, MPH
Associate Physician, Cardiovascular Division, Brigham and Women’s Hospital Investigator, TIMI Study Group Assistant Professor of Medicine, Harvard Medical School

Dr. Ruff graduated from Harvard University, earned his medical degree at Johns Hopkins University School of Medicine, and his masters of public health from the Harvard School of Public Health. Dr. Ruff is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Genetics Core Laboratory and the Co-Chairman of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator initiated studies of biomarkers and genetic variants to large clinical trials.

Registration

Register now to attend the 2017 Thrombosis Summit

Registration Price

49.99

Join NATF in the fight against blood clots. Donate today.

Make a donation

Twitter Facebook YouTube